Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2019 | 2017 | 2015
Number of items: 3.

2019

Liu, Pei Y., Tee, Andrew E., Milazzo, Giorgio, Hannan, Katherine M., Maag, Jesper ORCID: 0000-0002-2578-8872, Mondal, Sujanna, Atmadibrata, Bernard, Bartonicek, Nenad, Peng, Hui, Ho, Nicholas, Mayoh, Chelsea, Ciaccio, Roberto, Sun, Yuting, Henderson, Michelle J., Gao, Jixuan, Everaert, Celine ORCID: 0000-0001-7772-4259, Hulme, Amy J., Wong, Matthew ORCID: 0000-0003-2680-961X, Lan, Qing, Cheung, Belamy B., Shi, Leming, Wang, Jenny Y., Simon, Thorsten, Fischer, Matthias, Zhang, Xu D., Marshall, Glenn M., Norris, Murray D., Haber, Michelle, Vandesompele, Jo, Li, Jinyan, Mestdagh, Pieter, Hannan, Ross D., Dinger, Marcel E., Perini, Giovanni and Liu, Tao ORCID: 0000-0001-6244-7316 (2019). The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35. Nat. Commun., 10. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

2017

Jung, MoonSun, Russell, Amanda J., Liu, Bing, George, Joshy, Liu, Pei Yan, Liu, Tao ORCID: 0000-0001-6244-7316, DeFazio, Anna ORCID: 0000-0003-0057-4744, Bowtell, David D. L., Oberthuer, Andre, London, Wendy B., Fletcher, Jamie I., Haber, Michelle ORCID: 0000-0003-2036-8817, Norris, Murray D. and Henderson, Michelle J. (2017). A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers. Cancer Res., 77 (4). S. 971 - 982. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

2015

Haber, Michelle, Murray, Jayne, Gamble, Laura, Carnegie-Clark, Ashleigh, Webber, Hannah, Ruhle, Michelle, Henderson, Michelle J., Middlemass, Shiloh, Carter, Daniel, Tsoli, Maria, Ehteda, Anahid, Simon, Sandy, Oberthuer, Andre, Fischer, Matthias, Gurova, Katerina, Burkhart, Catherine, Purmal, Andrei, Lock, Richard B., Ziegler, David, Marshall, Glenn M., Gudkov, Andrei V. and Norris, Murray D. (2015). The FACT histone chaperone complex is highly expressed in aggressive drug refractory childhood cancers and the anti-FACT compound CBL0137 represents a highly promising therapeutic approach in this setting. Cancer Res., 75. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

This list was generated on Sat May 4 03:47:46 2024 CEST.